https://www.selleckchem.com/products/r428.html
Background Tuberculosis (T is a major global health problem and leading cause of death. Anti-tubercular therapy (ATT) can lead to various adverse effects including cutaneous reactions. Re-challenge remains the only option to restart the safe therapy with limited number of most efficient primary ATT drugs. Objectives To study the demographic profile, identify the spectrum of cutaneous eruptions, offending drug and the reinstitution of safe ATT. Materials and methods This was a retrospective study with inclusion of the indoor patients with
Like
Comment
Share
